Refine Results
  1. "Neuroblastoma Service"
Formats
  1. Journal Article (401)
  2. Meeting Abstract (194)
  3. Conference Paper (11)
  4. Book Section (8)
  5. Book Whole (1)
Groups
  1. Neuroblastoma Service (615)
  2. Pediatrics, Department of (615)
  3. Center for Hematologic Malignancies (170)
  4. Neuro-Oncology Service (163)
  5. Pediatric Leukemia (142)
  6. Radiology, Department of (118)

More Groups

People
  1. Nai-Kong Cheung (520)
  2. Brian Kushner (225)
  3. Shakeel Modak (181)
  4. Kim Kramer (150)
  5. Michael La Quaglia (90)
  6. Irene Cheung (76)

More People

Years
  1. 2020 (1)
  2. 2019 (36)
  3. 2018 (44)
  4. 2017 (39)
  5. 2016 (29)
  6. 2015 (29)

More Years

Publications
  1. Journal of Clinical Oncology (71)
  2. Pediatric Blood and Cancer (71)
  3. Cancer Research (33)
  4. Neuro-Oncology (26)
  5. International Journal of Radiation Oncology, Biology, Physics (24)
  6. Clinical Cancer Research (23)

More Publications

Publishers
  1. American Association for Cancer Research (84)
  2. Wiley Periodicals, Inc (74)
  3. American Society of Clinical Oncology (72)
  4. Elsevier Inc. (44)
  5. Oxford University Press (30)
  6. Nature Publishing Group (26)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel alterations in CSF1R, RET, and other diverse kinases in the histiocytoses with biochemical and structural insights into their mechanisms of activation
    Meeting Abstract

    Durham, B.; Lopez-Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S.; Pastore, A.; Mandelker, D.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Biodistribution and dosimetry of intraventricularly administered (124)I-omburtamab in patients with metastatic leptomeningeal tumors
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Kramer, K.; Grkovski, M.; Fung, E. K.; Shi, W.; Zhang, Z.; Lyashchenko, S. K.; Fung, A. M.; Pentlow, K. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Silencing Fc domains in T cell-engaging bispecific antibodies improves t-cell trafficking and antitumor potency
    Journal Article

    Wang, L.; Hoseini, S. S.; Xu, H.; Ponomarev, V.; Cheung, N. K.
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures
    Journal Article

    Qadeer, Z. A.; Valle-Garcia, D.; Hasson, D.; Sun, Z.; Cook, A.; Nguyen, C.; Soriano, A.; Ma, A.; Griffiths, L. M.; Zeineldin, M.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular 131I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Donzelli, M.; Suzanne, W.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M.; Greenfield, J.; Carrasquillo, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save